Article
Defining Cardiomyocyte Repolarization Response to Pharmacotherapy in Long-QT Syndrome Type 3.
Journal of the American Heart Association - 15 Oct 2024
Ge Ning, Li Rui, Liu Min, Xia Wenxin, O'Brien Stephen T, McInerney Veronica, Galvin Joseph, Ward Deirdre, McGorrian Catherine, O'Brien Timothy, Shen Sanbing, Prendiville Terence W
Abstract excerpt
BACKGROUND: Long-QT syndrome is a primary cardiac ion channelopathy predisposing a patient to ventricular arrhythmia through delayed repolarization on the resting ECG. We aimed to establish a patient-specific, human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes model of long-QT syndrome type 3 (LQT3) using clustered regularly interspaced palindromic repeats (CRISPR/Cas9), for disease modeling and...
Topics
Join the communities discussing this publication.
